U.S. OKs 1st drug aimed at women with inherited breast cancer
On Friday, the Food and Drug Administration approved AstraZeneca PLC’s Lynparza, the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene.Courtesy of AstraZeneca via…